Krisa Van Meurs

Publication Details

  • ECMO for neonatal respiratory failure SEMINARS IN PERINATOLOGY Bahrami, K. R., Van Meurs, K. P. 2005; 29 (1): 15-23


    Extracorporeal membrane oxygenation (ECMO) has been offered as a life-saving technology to newborns with respiratory and cardiac failure refractory to maximal medical therapy. ECMO has been used in treatment of neonates with a variety of cardio-respiratory problems, including meconium aspiration syndrome (MAS), persistent pulmonary hypertension of the neonate (PPHN), congenital diaphragmatic hernia (CDH), sepsis/pneumonia, respiratory distress syndrome (RDS), air leak syndrome, and cardiac anomalies. For this group of high-risk neonates with an anticipated mortality rate of 80% to 85%, ECMO has an overall survival rate of 84%, with recent data showing nearly 100% survival in many diagnostic groups. This article reviews the current selection criteria for ECMO and the clinical management of neonates on ECMO, and discusses the long-term outcome of neonates treated with ECMO.

    View details for DOI 10.1053/j.semperi.2005.02.004

    View details for Web of Science ID 000228783700004

    View details for PubMedID 15921148

Stanford Medicine Resources:

Footer Links: